Meet the Editorial Team
Kimberly Bertrand, ScD, is Assistant Professor at the Boston University School of Medicine and Epidemiologist at the Slone Epidemiology Center at Boston University. Dr. Bertrand’s current research efforts focus on understanding racial disparities in cancer incidence and outcomes, primarily for breast cancer. Other areas of research interest include the epidemiology of non-Hodgkin lymphoma and multiple myeloma. The majority of her research to date has been based in large, well-established cohorts and has focused on modifiable lifestyle risk factors. She also has experience in the analysis of geospatial-based exposures in relation to cancer as well as biomarker-based epidemiologic studies.
Theodore M. Brasky, PhD, is an Assistant Professor and Cancer Epidemiologist at The Ohio State University College of Medicine. Dr. Brasky has several research interests, including the relation of diet, dietary supplements, and medications with cancer risk and progression. Dr. Brasky has a secondary interest in tobacco cessation and use of novel tobacco products in cancer patients.
Holly R. Harris, ScD, MPH, is Assistant Member at the Fred Hutchinson Cancer Research Center, Seattle. Dr. Harris’s research broadly examines lifestyle, nutrition, and genetic factors and their impact on women’s health. Specifically, it is focused on ovarian and breast cancer, as well as hormonally related conditions that have shared reproductive risk factors with these diseases, including endometriosis and uterine fibroids. Her research aims to understand the role of the modifiable factors across the life course (e.g., diet and lifestyle) on the risk of these conditions using both observational cohorts and intervention studies. In addition, Dr. Harris’s research examines the interrelatedness of non-malignant and malignant conditions and their shared risk factors. In particular, focusing on understanding the endometriosis to ovarian cancer transition and identifying sub-groups of women that would most benefit from ovarian cancer screening modalities that are not currently appropriate for population-based use.
Jaime E. Hart, ScD, is Assistant Professor at the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School and the Department of Environmental Health at the Harvard TH Chan School of Public Health. Dr. Hart’s research focuses on the impacts of environmental exposures on chronic disease risk and on examining the impacts of multiple exposures simultaneously (e.g. the external exposome). She also has a strong emphasis on applying spatial methods and geographic information systems (GIS) to develop exposure models, map patterns of diseases and exposures, and append contextual measures to long standing prospective cohorts.
Michelle D. Holmes, MD, DrPH, is an associate professor of medicine at Harvard Medical School and an associate professor in the department of Epidemiology at Harvard School of Public Health. Her research interests include lifestyle factors (diet, weight change, physical activity, and psychosocial factors, common medications like aspirin) affecting quality of life and survival after a cancer diagnosis, as well as the association between diet and breast cancer risk. She has helped to design a collaborative longitudinal study of non-communicable disease (obesity, diabetes, high blood pressure, heart disease, cancer) at 5 sites in sub-Saharan Africa.
Michael Leitzmann, MD, DrPH, is a professor in the Department of Epidemiology and Preventive Medicine at the University of Regensburg, Germany. Dr. Leitzmann’s research focuses on the independent and joint relations of body mass, physical activity, sedentary behavior, and diet in relation to cancer incidence and survival. His energy balance research is characterized by the development and application of methods to validly measure body composition and energy expenditure in large population-based cohorts. He has helped design and implement the German National Cohort, a large prospective cohort study of non-communicable and communicable disease endpoints.
Jason Liu, ScD, MS, MPH, is an Assistant Professor at National Yang-Ming University's Institute of Public Health in Taipei, Taiwan. His research interests include cancer incidence and mortality trends, cancer survivors' health, as well as biomarkers and other predictors of cancer risk. He is studying the incidence rates of childhood, adolescent, and young adulthood cancers in Taiwan, and the associations between these cancers and subsequent health outcomes.
Sarah Markt, ScD, MPH is Assistant Professor in the Department of Population and Quantitative Health Sciences at the Case Western Reserve University School of Medicine. Dr. Markt’s research integrates molecular, lifestyle, and clinical epidemiology to study risk factors for initiation and progression of cancer, with the primary goal to translate research findings into direct application for primary and secondary cancer prevention. Her work has utilized data from large population based cohorts from the United States, Sweden, Iceland, and Finland, and clinical cohorts from electronic health record data. Her research is primarily focused on understanding the role of modifiable lifestyle factors (sleep, weight, physical activity) and genomic tumor biomarkers in prostate, bladder and testicular cancer risk and progression.
Alison M. Mondul, PhD, MSPH, is an Assistant Professor in the Department of Epidemiology at the University of Michigan School of Public Health. Dr. Mondul studies the role of modifiable risk factors in the etiology of cancer. In particular,she studies how lifestyle factors (such as use of common medications) and factors related to diet and nutrition (such as micronutrients and lipids) may influence prostate and head and neck cancers, as well as benign prostatic hyperplasia. In order to study these associations Dr. Mondul employs molecular epidemiologic techniques including hypothesis-driven studies of serum biomarkers, genome-wide association studies, and metabolomic profiling.
Jessica Petrick, PhD, MPH, is an Assistant Professor at the Boston University School of Medicine and Epidemiologist at the Slone Epidemiology Center at Boston University. Dr. Petrick’s research focuses on the epidemiology of gastrointestinal cancers, including colorectal, liver, and esophageal. The emphasis of her current research is on nutritional and molecular factors, including the metabolome and microbiome, which may contribute to health disparities along the cancer continuum—from precursor lesions to invasive cancer through mortality.
Jenny N. Poynter, PhD, is an Associate Professor in the Division of Epidemiology and Clinical Research in the Department of Pediatrics at the University of Minnesota. Dr. Poynter’s primary research is focused on the role of genetic and epigenetic alterations in the etiology of pediatric germ cell tumors and myeloid malignancy. She has an ongoing NIH-funded research study to support this work. Her laboratory work is focused on DNA methylation, genomic imprinting and susceptibility to childhood and adult cancers. Dr. Poynter is the Associate Director of Community Outreach and Engagement at the University of Minnesota Masonic Cancer Center and the Vice Chair of the Children’s Oncology Group Epidemiology Committee.
Jennifer R. Rider, ScD, MPH is an Assistant Professor in the Department of Epidemiology at the Boston University of Public Health. Dr. Rider’s research focuses primarily on prostate cancer, but also includes studies of penile cancer, bladder cancer, and tumors of the head and neck. She is interested in the role of modifiable lifestyle factors in cancer development and progression, as well as the identification of tumor biomarkers that can improve disease management. Dr. Rider is currently leading projects that address methodological challenges in the development of novel prostate cancer therapies, including the evaluation of surrogate endpoints. Dr. Rider’s research utilizes data from U.S.-based prospective cohorts, several studies based in Sweden, and electronic health record-derived data from clinical cohorts.
Fred K. Tabung, PhD, MSPH, is an Assistant Professor at The Ohio State University College of Medicine and Comprehensive Cancer Center. Dr. Tabung’s research involves the role of dietary patterns and lifestyle factors in cancer risk and treatment response, specifically among patients with gastrointestinal tract cancers. This work is conducted mainly through the integration of novel dietary patterns, biomarkers, metabolomics, and gut microbiome data to comprehensively investigate and identify potential biological pathways linking dietary patterns and cancer risk and survival. An important aspect of Dr Tabung’s research effort is the translation of research findings from large epidemiological cohorts into the clinical setting using randomized dietary intervention trials, to determine dietary patterns for healthy eating and develop therapeutic diets.
Britton Trabert, PhD, MS, is Earl Stadtman Investigator at the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, NIH, DHHS. Dr. Trabert’s research focuses on the hormonal etiology of female cancers and the epidemiology and etiologic heterogeneity of ovarian and endometrial cancers. Specifically, she has focused on clarifying the role of both systemic and local inflammation in ovarian and endometrial carcinogenesis. Dr. Trabert has contributed significantly to improving the scientific understanding of the relationship between exogenous hormone use and endogenous hormone levels and female cancer risk. Dr. Trabert’s diverse research portfolio has included methodologic validation of hormone assays and evaluation of cancer trends using US and international cancer registries as well as the evaluation of cancer risk factors in large population-based case-control and cohort studies and in international consortia. She also has considerable expertise leading molecular epidemiologic studies.
Lusine Yaghjyan, MD, PhD, is an Assistant Professor and an Epidemiologist at the University of Florida College of Public Health and Health Professions and College of Medicine. Dr. Yaghjayn’s research primarily focuses on etiology and molecular epidemiology of breast cancer, benign breast disease, and high mammographic breast density. She has been working with several well-established cohorts to examine associations of various factors early in life and in adulthood with these outcomes. Dr. Yaghjyan currently focuses on emerging areas in breast cancer research, such as potential application of breast stem cell markers for risk prediction in women with benign breast biopsies and contributions of gut microbiota to breast carcinogenesis. Other areas of her research include the role of environmental risk factors, such as endocrine disruptors and air pollution, in breast cancer etiology.